Immunotherapy With Racotumomab in Advanced Lung Cancer

NCT01460472 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1082

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC
Lung Cancer, Non-small Cell

Interventions

BIOLOGICAL: Racotumomab
OTHER: Best Support Treatment

Sponsor

Recombio SL

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]